Last 12 months
Inside the activity.
0 purchase rows · 31 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 11 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 15 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 3 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 15, 2021 Filed Dec 7, 2021 18:28 UTC |
Grabowski Mary TheresaChief Human Resources Officer
|
GrantRestricted Stock Units · Derivative | 9.4376 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-030425 · form4.xml · derivative · entry 5 Grabowski Mary Theresa · CIK 0001747030 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47.0365 Underlying: Common Stock · 9.4376 shares Expires not disclosed F3 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F4 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F4 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| November 15, 2021 Filed Dec 7, 2021 18:30 UTC |
Pritchard Marc S.Chief Brand Officer
|
GrantRestricted Stock Units · Derivative | 171.5477 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-030426 · form4.xml · derivative · entry 8 Pritchard Marc S. · CIK 0001440364 · Chief Brand Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,827.4733 Underlying: Common Stock · 171.5477 shares Expires not disclosed F3 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F4 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F4 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| November 15, 2021 Filed Dec 7, 2021 18:34 UTC |
Majoras Deborah PChief Legal Officer & Secy
|
GrantRestricted Stock Units · Derivative | 76.1795 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-030428 · form4.xml · derivative · entry 8 Majoras Deborah P · CIK 0001483177 · Chief Legal Officer & Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,021.4055 Underlying: Common Stock · 76.1795 shares Expires not disclosed F3 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F4 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F4 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| November 15, 2021 Filed Dec 7, 2021 18:32 UTC |
Raman Sundar G.CEO-Fabric & Home Care
|
GrantRestricted Stock Units · Derivative | 5.9378 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-030427 · form4.xml · derivative · entry 4 Raman Sundar G. · CIK 0001882672 · CEO-Fabric & Home Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5.9378 Underlying: Common Stock · 5.9378 shares Expires not disclosed F3 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F4 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F4 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| November 15, 2021 Filed Dec 7, 2021 18:40 UTC |
Schulten AndreChief Financial Officer
|
GrantRestricted Stock Units · Derivative | 3.2224 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-030429 · form4.xml · derivative · entry 4 Schulten Andre · CIK 0001844763 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3.2224 Underlying: Common Stock · 3.2224 shares Expires not disclosed F3 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F4 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F4 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| November 15, 2021 Filed Dec 7, 2021 18:44 UTC |
TASTAD CAROLYN MCEO - Health Care
|
GrantRestricted Stock Units · Derivative | 39.4004 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-030431 · form4.xml · derivative · entry 8 TASTAD CAROLYN M · CIK 0001597938 · CEO - Health Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 620.1055 Underlying: Common Stock · 39.4004 shares Expires not disclosed F3 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F4 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F4 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| November 15, 2021 Filed Dec 7, 2021 18:49 UTC |
Jejurikar ShaileshChief Operating Officer
|
GrantRestricted Stock Units · Derivative | 17.8749 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-030433 · form4.xml · derivative · entry 7 Jejurikar Shailesh · CIK 0001746310 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 182.5825 Underlying: Common Stock · 17.8749 shares Expires not disclosed F5 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F6 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F6 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| November 15, 2021 Filed Dec 7, 2021 18:45 UTC |
Aguilar Moses Victor JavierChf Rsch, Dev & Innov Officer
|
GrantRestricted Stock Units · Derivative | 2.0931 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-030432 · form4.xml · derivative · entry 8 Aguilar Moses Victor Javier · CIK 0001825382 · Chf Rsch, Dev & Innov Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2.0931 Underlying: Common Stock · 2.0931 shares Expires not disclosed F3 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F4 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F4 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| November 10, 2021 Filed Nov 12, 2021 21:18 UTC |
Taylor David SDirector · Executive Chairman
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $80.29 | $0.00 |
DisclosureSEC source: 0001127602-21-028965 · form4.xml · derivative · entry 4 Taylor David S · CIK 0001505989 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,095 Underlying: Common Stock · 50,000 shares Expires 2026-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 10, 2021 Filed Nov 12, 2021 21:18 UTC |
Taylor David SDirector · Executive Chairman
|
SaleCommon Stock | 50,000 | $146.00 | $7,300,110.00 |
DisclosureSEC source: 0001127602-21-028965 · form4.xml · nonDerivative · entry 2 Taylor David S · CIK 0001505989 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 266,980.6007 F1 · price: Weighted average price of the shares sold. The price range was $146.00 to $146.035. Full information regarding the number of shares sold at each separate price available upon request. Read SEC document |
| November 10, 2021 Filed Nov 12, 2021 21:18 UTC |
Taylor David SDirector · Executive Chairman
|
Exercise / conversionCommon Stock | 50,000 | $80.29 | $4,014,500.00 |
DisclosureSEC source: 0001127602-21-028965 · form4.xml · nonDerivative · entry 1 Taylor David S · CIK 0001505989 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 316,980.6007 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 10, 2021 Filed Nov 12, 2021 21:14 UTC |
Homan Michael G.SVP - Chief Accounting Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $85.13 | $0.00 |
DisclosureSEC source: 0001127602-21-028961 · form4.xml · derivative · entry 4 Homan Michael G. · CIK 0001847579 · SVP - Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,134 Underlying: Common Stock · 10,000 shares Expires 2025-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 10, 2021 Filed Nov 12, 2021 21:14 UTC |
Homan Michael G.SVP - Chief Accounting Officer
|
SaleCommon Stock | 10,000 | $146.81 | $1,468,111.00 |
DisclosureSEC source: 0001127602-21-028961 · form4.xml · nonDerivative · entry 2 Homan Michael G. · CIK 0001847579 · SVP - Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,914.1856 F1 · price: Weighted average price of the shares sold. The price range was $146.80 to $146.841. Full information regarding the number of shares sold at each separate price available upon request. Read SEC document |
| November 10, 2021 Filed Nov 12, 2021 21:14 UTC |
Homan Michael G.SVP - Chief Accounting Officer
|
Exercise / conversionCommon Stock | 10,000 | $85.13 | $851,300.00 |
DisclosureSEC source: 0001127602-21-028961 · form4.xml · nonDerivative · entry 1 Homan Michael G. · CIK 0001847579 · SVP - Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,914.1856 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 05, 2021 Filed Nov 8, 2021 14:40 UTC |
Francisco Ma. FatimaCEO - Baby, Fem & Family Care
|
SaleCommon Stock | 3,400 | $146.00 | $496,400.00 |
DisclosureSEC source: 0001127602-21-028510 · form4.xml · nonDerivative · entry 1 Francisco Ma. Fatima · CIK 0001747222 · CEO - Baby, Fem & Family Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,008.38 Read SEC document |
| November 03, 2021 Filed Nov 4, 2021 13:33 UTC |
Francisco Ma. FatimaCEO - Baby, Fem & Family Care
|
SaleCommon Stock | 3,400 | $145.00 | $493,000.00 |
DisclosureSEC source: 0001127602-21-028368 · form4.xml · nonDerivative · entry 1 Francisco Ma. Fatima · CIK 0001747222 · CEO - Baby, Fem & Family Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,408.38 Read SEC document |
| October 29, 2021 Filed Dec 7, 2021 18:49 UTC |
Jejurikar ShaileshChief Operating Officer
|
GiftCommon Stock | 19,757 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-030433 · form4.xml · nonDerivative · entry 1 Jejurikar Shailesh · CIK 0001746310 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Shailesh Jejurikar Trust Disclosed balance after: 0 F1 · shares: On October 29, 2021, the reporting person transferred 19,757 shares of common stock to a family trust, of which the reporting person is a trustee. The reporting person and his spouse are the sole beneficiaries of the trust. F1 · balance_after: On October 29, 2021, the reporting person transferred 19,757 shares of common stock to a family trust, of which the reporting person is a trustee. The reporting person and his spouse are the sole beneficiaries of the trust. F2 · balance_after: On October 29, 2021, the reporting person contributed 19,750 shares of common stock to a grantor retained annuity trust, of which the reporting person is the trustee, for the benefit of himself and his children. Read SEC document |
| October 26, 2021 Filed Oct 26, 2021 20:36 UTC |
Francisco Ma. FatimaCEO - Baby, Fem & Family Care
|
SaleCommon Stock | 1,200 | $143.00 | $171,600.00 |
DisclosureSEC source: 0001127602-21-027651 · form4.xml · nonDerivative · entry 1 Francisco Ma. Fatima · CIK 0001747222 · CEO - Baby, Fem & Family Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,808.38 Read SEC document |
| October 22, 2021 Filed Oct 25, 2021 18:44 UTC |
Raman Sundar G.CEO-Fabric & Home Care
|
OtherCommon Stock | 2,542.1665 | $140.58 | $357,368.11 |
DisclosureSEC source: 0001127602-21-027554 · form4.xml · nonDerivative · entry 1 Raman Sundar G. · CIK 0001882672 · CEO-Fabric & Home Care 10b5-1 filing: Not disclosed Ownership: Indirect · By Retirement Plan Trustee Disclosed balance after: 5,982.8319 Read SEC document |
| October 12, 2021 Filed Oct 14, 2021 17:23 UTC |
Allen Bertrand MarcDirector
|
GrantCommon Stock | 1,408 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-027056 · form4.xml · nonDerivative · entry 1 Allen Bertrand Marc · CIK 0001632131 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,968.93 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. Read SEC document |
| October 12, 2021 Filed Oct 14, 2021 17:25 UTC |
Braly Angela FDirector
|
GrantCommon Stock | 1,408 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-027057 · form4.xml · nonDerivative · entry 1 Braly Angela F · CIK 0001321458 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,845.4628 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. Read SEC document |
| October 12, 2021 Filed Oct 14, 2021 17:27 UTC |
Chang AmyDirector
|
GrantCommon Stock | 1,408 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-027058 · form4.xml · nonDerivative · entry 1 Chang Amy · CIK 0001551504 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,611.783 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. Read SEC document |
| October 12, 2021 Filed Oct 14, 2021 17:30 UTC |
JIMENEZ JOSEPHDirector
|
GrantCommon Stock | 1,408 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-027059 · form4.xml · nonDerivative · entry 1 JIMENEZ JOSEPH · CIK 0001199095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,546.739 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. Read SEC document |
| October 12, 2021 Filed Oct 14, 2021 17:31 UTC |
Kempczinski Christopher JDirector
|
GrantCommon Stock | 1,408 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-027060 · form4.xml · nonDerivative · entry 1 Kempczinski Christopher J · CIK 0001598115 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,408 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. Read SEC document |
| October 12, 2021 Filed Oct 14, 2021 17:36 UTC |
McCarthy Christine MDirector
|
GrantCommon Stock | 1,408 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-027062 · form4.xml · nonDerivative · entry 1 McCarthy Christine M · CIK 0001332169 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,206.206 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock & Incentive Compensation Plan. Read SEC document |
| October 12, 2021 Filed Oct 14, 2021 17:39 UTC |
LUNDGREN TERRY JDirector
|
GrantCommon Stock | 1,408 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-027063 · form4.xml · nonDerivative · entry 1 LUNDGREN TERRY J · CIK 0001184471 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,567.417 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. Read SEC document |
| October 12, 2021 Filed Oct 14, 2021 17:45 UTC |
WOERTZ PATRICIA ADirector
|
GrantCommon Stock | 1,408 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-027065 · form4.xml · nonDerivative · entry 1 WOERTZ PATRICIA A · CIK 0001194945 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,295.717 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. Read SEC document |
| October 12, 2021 Filed Oct 14, 2021 18:48 UTC |
LEE DEBRA LDirector
|
GrantCommon Stock | 1,408 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-027069 · form4.xml · nonDerivative · entry 1 LEE DEBRA L · CIK 0001119838 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,828.663 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units. Read SEC document |
| October 12, 2021 Filed Oct 14, 2021 19:50 UTC |
WHITMAN MARGARET CDirector
|
GrantCommon Stock | 1,408 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-027071 · form4.xml · nonDerivative · entry 1 WHITMAN MARGARET C · CIK 0001079816 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,955.035 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 14:38 UTC |
Taylor David SDirector · Chairman, President & CEO
|
GrantStock Option (Right to Buy) · Derivative | 187,212 | $0.00 Strike: $139.58 | $0.00 |
DisclosureSEC source: 0001127602-21-026600 · form4.xml · derivative · entry 4 Taylor David S · CIK 0001505989 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 187,212 Underlying: Common Stock · 187,212 shares Expires 2031-10-01 Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 14:38 UTC |
Taylor David SDirector · Chairman, President & CEO
|
GrantCommon Stock | 15,673 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-026600 · form4.xml · nonDerivative · entry 1 Taylor David S · CIK 0001505989 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 266,980.6007 F1 · price: Restricted Stock Units awarded pursuant to Issuer's 2019 Stock and Incentive Compensation Plan. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 14:40 UTC |
Francisco Ma. FatimaCEO - Baby, Fem & Family Care
|
GrantStock Option (Right to Buy) · Derivative | 82,489 | $0.00 Strike: $139.58 | $0.00 |
DisclosureSEC source: 0001127602-21-026601 · form4.xml · derivative · entry 5 Francisco Ma. Fatima · CIK 0001747222 · CEO - Baby, Fem & Family Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,489 Underlying: Common Stock · 82,489 shares Expires 2031-10-01 Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 14:41 UTC |
Homan Michael G.SVP - Chief Accounting Officer
|
GrantStock Option (Right to Buy) · Derivative | 18,215 | $0.00 Strike: $139.58 | $0.00 |
DisclosureSEC source: 0001127602-21-026602 · form4.xml · derivative · entry 4 Homan Michael G. · CIK 0001847579 · SVP - Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,215 Underlying: Common Stock · 18,215 shares Expires 2031-10-01 Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 14:42 UTC |
Jejurikar ShaileshChief Operating Officer
|
GrantStock Option (Right to Buy) · Derivative | 92,166 | $0.00 Strike: $139.58 | $0.00 |
DisclosureSEC source: 0001127602-21-026603 · form4.xml · derivative · entry 5 Jejurikar Shailesh · CIK 0001746310 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,166 Underlying: Common Stock · 92,166 shares Expires 2031-10-01 Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 14:46 UTC |
Pritchard Marc S.Chief Brand Officer
|
GrantStock Option (Right to Buy) · Derivative | 68,457 | $0.00 Strike: $139.58 | $0.00 |
DisclosureSEC source: 0001127602-21-026606 · form4.xml · derivative · entry 8 Pritchard Marc S. · CIK 0001440364 · Chief Brand Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,457 Underlying: Common Stock · 68,457 shares Expires 2031-10-01 Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 14:44 UTC |
Grabowski Mary TheresaChief Human Resources Officer
|
GrantStock Option (Right to Buy) · Derivative | 44,333 | $0.00 Strike: $139.58 | $0.00 |
DisclosureSEC source: 0001127602-21-026605 · form4.xml · derivative · entry 5 Grabowski Mary Theresa · CIK 0001747030 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,333 Underlying: Common Stock · 44,333 shares Expires 2031-10-01 Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 14:44 UTC |
Grabowski Mary TheresaChief Human Resources Officer
|
GrantCommon Stock | 2,298 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-026605 · form4.xml · nonDerivative · entry 1 Grabowski Mary Theresa · CIK 0001747030 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,251.368 F1 · price: Restricted Stock Units awarded pursuant to issuer's 2019 Stock and Incentive Compensation Plan. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 14:47 UTC |
Aguilar Moses Victor JavierChf Rsch, Dev & Innov Officer
|
GrantStock Option (Right to Buy) · Derivative | 52,673 | $0.00 Strike: $139.58 | $0.00 |
DisclosureSEC source: 0001127602-21-026607 · form4.xml · derivative · entry 5 Aguilar Moses Victor Javier · CIK 0001825382 · Chf Rsch, Dev & Innov Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,673 Underlying: Common Stock · 52,673 shares Expires 2031-10-01 Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 15:04 UTC |
TASTAD CAROLYN MCEO - Health Care
|
GrantStock Option (Right to Buy) · Derivative | 62,731 | $0.00 Strike: $139.58 | $0.00 |
DisclosureSEC source: 0001127602-21-026608 · form4.xml · derivative · entry 6 TASTAD CAROLYN M · CIK 0001597938 · CEO - Health Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,731 Underlying: Common Stock · 62,731 shares Expires 2031-10-01 Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 15:04 UTC |
TASTAD CAROLYN MCEO - Health Care
|
GrantCommon Stock | 3,251 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-026608 · form4.xml · nonDerivative · entry 1 TASTAD CAROLYN M · CIK 0001597938 · CEO - Health Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,748.3632 F1 · price: Restricted Stock Units awarded pursuant to Issuer's 2019 Stock and Incentive Compensation Plan. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 15:07 UTC |
Schulten AndreChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 62,212 | $0.00 Strike: $139.58 | $0.00 |
DisclosureSEC source: 0001127602-21-026609 · form4.xml · derivative · entry 4 Schulten Andre · CIK 0001844763 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,212 Underlying: Common Stock · 62,212 shares Expires 2031-10-01 Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 15:07 UTC |
Schulten AndreChief Financial Officer
|
GrantCommon Stock | 3,224 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-026609 · form4.xml · nonDerivative · entry 1 Schulten Andre · CIK 0001844763 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,289.7766 F1 · price: Restricted Stock Units awarded pursuant to issuer's 2019 Stock and Incentive Compensation Plan. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 15:08 UTC |
Raman Sundar G.CEO-Fabric & Home Care
|
GrantStock Option (Right to Buy) · Derivative | 74,240 | $0.00 Strike: $139.58 | $0.00 |
DisclosureSEC source: 0001127602-21-026610 · form4.xml · derivative · entry 3 Raman Sundar G. · CIK 0001882672 · CEO-Fabric & Home Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,240 Underlying: Common Stock · 74,240 shares Expires 2031-10-01 Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 15:10 UTC |
Majoras Deborah PChief Legal Officer & Secy
|
GrantStock Option (Right to Buy) · Derivative | 35,715 | $0.00 Strike: $139.58 | $0.00 |
DisclosureSEC source: 0001127602-21-026611 · form4.xml · derivative · entry 4 Majoras Deborah P · CIK 0001483177 · Chief Legal Officer & Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,715 Underlying: Common Stock · 35,715 shares Expires 2031-10-01 Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 15:10 UTC |
Majoras Deborah PChief Legal Officer & Secy
|
GrantCommon Stock | 5,553 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-026611 · form4.xml · nonDerivative · entry 1 Majoras Deborah P · CIK 0001483177 · Chief Legal Officer & Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,221.5285 F1 · price: Restricted Stock Units awarded pursuant to Issuer's 2019 Stock and Incentive Compensation Plan. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 15:12 UTC |
Moeller Jon RVice Chairman and COO
|
GrantStock Option (Right to Buy) · Derivative | 154,839 | $0.00 Strike: $139.58 | $0.00 |
DisclosureSEC source: 0001127602-21-026612 · form4.xml · derivative · entry 4 Moeller Jon R · CIK 0001450613 · Vice Chairman and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,839 Underlying: Common Stock · 154,839 shares Expires 2031-10-01 Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 15:12 UTC |
Moeller Jon RVice Chairman and COO
|
GrantCommon Stock | 16,049 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-026612 · form4.xml · nonDerivative · entry 1 Moeller Jon R · CIK 0001450613 · Vice Chairman and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 167,926.4116 F1 · price: Restricted Stock Units awarded pursuant to Issuer's 2019 Stock and Incentive Compensation Plan. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 15:13 UTC |
Keith R. AlexandraCEO - Beauty
|
GrantStock Option (Right to Buy) · Derivative | 13,525 | $0.00 Strike: $139.58 | $0.00 |
DisclosureSEC source: 0001127602-21-026613 · form4.xml · derivative · entry 8 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 13,525 Underlying: Common Stock · 13,525 shares Expires 2031-10-01 Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 15:13 UTC |
Keith R. AlexandraCEO - Beauty
|
GrantStock Option (Right to Buy) · Derivative | 65,824 | $0.00 Strike: $139.58 | $0.00 |
DisclosureSEC source: 0001127602-21-026613 · form4.xml · derivative · entry 7 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,824 Underlying: Common Stock · 65,824 shares Expires 2031-10-01 Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 15:13 UTC |
Keith R. AlexandraCEO - Beauty
|
GrantCommon Stock | 701 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-026613 · form4.xml · nonDerivative · entry 2 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 6,636.7842 F1 · price: Restricted Stock Units awarded pursuant to issuer's 2019 Stock and Incentive Compensation Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.